Contemporary Outcomes Among Gynecologic Oncology Patients With Malignant Small Bowel Obstructions
American Journal of Hospice and Palliative Medicine® · 24.05.2026
DOI: 10.1177/10499091261454356 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Hospice and Palliative Medicine®, online erschienen am 24.05.2026. Verfasst von Gabriela Weigel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Warren Albert Medical School of Brown University, Women and Infants Hospital, Providence, RI, USA. Die Arbeit nennt 13 Literaturangaben.
Abstract (Originalsprache)
Objective
Malignant bowel obstructions (MBOs) are common sequelae of advanced gynecologic malignancies, accompanied by significant morbidity and mortality. Little evidence exists to guide optimal management. We aimed to describe contemporary outcomes for gynecologic oncology patients with MBOs to inform prospective management strategies.
Methods
We conducted a retrospective chart review of gynecologic oncology admissions for malignant small bowel obstructions at a single academic institution from 1/2019 to 12/2023. Variables included cancer type, treatment phase, management interventions, goals of care conversations, readmissions, hospice utilization and death. Descriptive statistics were utilized for analysis.
Results
Sixty-nine patients (119 admissions) were included. Most patients had ovarian cancer (82%), in treatment for recurrence (65%) or diagnosed with a new recurrence (17%). Bowel decompression occurred during most admissions (nasogastric tubes 50%, gastrostomy tubes 18%). Use of total parenteral nutrition (TPN) (30%), chemotherapy (12%) and surgery (2.5%) were less common. Return of flatus was noted in 76% of admissions, but only 39% were discharged on a regular diet as opposed to full or clear liquids or TPN. Goals of care conversations were documented for 34% of admissions. Readmission within 30 days was common (39%), typically for recurrent obstructions. Of 69 patients, from initial MBO admission, 28% utilized hospice within 30 days, 13% died within 30 days and 61% died within 6 months.
Conclusion
MBOs were associated with high rates of readmission, hospice utilization and death, with variable management strategies employed. Given the poor prognosis, evidence-based strategies to optimize care for these patients is warranted.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Warren Albert Medical School of Brown University, Women and Infants Hospital, Providence, RI, USA.
ORCID-Profile: Gabriela Weigel
Zitieren
APA
Weigel, G., Salinaro, J., Hemphill, J., Paterson, V., Hahn, M., Mathews, C., & Miller, K. (2026). Contemporary Outcomes Among Gynecologic Oncology Patients With Malignant Small Bowel Obstructions. American Journal of Hospice and Palliative Medicine®. https://doi.org/10.1177/10499091261454356
Vancouver
Weigel G, Salinaro J, Hemphill J, Paterson V, Hahn M, Mathews C, et al. Contemporary Outcomes Among Gynecologic Oncology Patients With Malignant Small Bowel Obstructions. American Journal of Hospice and Palliative Medicine®. 2026. doi:10.1177/10499091261454356
BibTeX
@article{Weigel2026,
author = {Weigel, Gabriela and Salinaro, Julia and Hemphill, Julie and Paterson, Victoria and Hahn, Marina and Mathews, Cara and Miller, Katherine},
title = {Contemporary Outcomes Among Gynecologic Oncology Patients With Malignant Small Bowel Obstructions},
journal = {American Journal of Hospice and Palliative Medicine®},
year = {2026},
doi = {10.1177/10499091261454356}
}
EUVIMED